Yuma Regional Medical Center
- Type
- Teaching hospital
- Where
- YUMA, AZ
- Medicare CCN
- 030013
- Received
- $144,714 in 56 records, 2020 ($31,195 general, $113,519 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Plan sponsor: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Trademark owner: Yuma Regional Medical Center Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 15 | $31,195 |
| 2020 | Research payment | 41 | $113,519 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $32,400 | 2020 |
| Eli Lilly and Company | 2 | $23,827 | 2020 |
| Linvatec Corporation | 2 | $23,533 | 2020 |
| Surmodics, Inc. | 17 | $19,196 | 2020 |
| Boston Scientific Corporation | 18 | $15,637 | 2020 |
| Novartis Pharmaceuticals Corporation | 1 | $15,580 | 2020 |
| Incyte Corporation | 2 | $6,878 | 2020 |
| AngioDynamics, Inc. | 6 | $4,304 | 2020 |
| Medartis Inc. | 1 | $2,732 | 2020 |
| STERIS CORPORATION | 1 | $250 | 2020 |
| Vitalant | 2 | $170 | 2020 |
| Siemens Medical Solutions USA, Inc. | 1 | $148 | 2020 |
| Masimo Corporation | 2 | $56 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 41 | $113,519 |
| Grant | 2 | $23,533 |
| Education | 8 | $4,360 |
| Gift | 2 | $2,982 |
| Space rental or facility fees (teaching hospital only) | 2 | $170 |
| Charitable Contribution | 1 | $148 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Linvatec Corporation | $16,670 | Grant | In-kind items and services | 2DHD CAMERAS Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-12-31 | Medartis Inc. | $2,732 | Gift (4 payments) | In-kind items and services | APTUS Device, ORTHO | 2020 | |
| 2020-12-31 | AngioDynamics, Inc. | $1,400 | Education | In-kind items and services | Celerity Device, Vascular Access | 2020 | |
| 2020-12-31 | AngioDynamics, Inc. | $1,400 | Education | In-kind items and services | Celerity Device, Vascular Access | 2020 | |
| 2020-12-31 | AngioDynamics, Inc. | $1,400 | Education | In-kind items and services | Celerity Device, Vascular Access | 2020 | |
| 2020-12-31 | Siemens Medical Solutions USA, Inc. | $148 | Charitable Contribution | In-kind items and services | 2020 | ||
| 2020-12-31 | AngioDynamics, Inc. | $34 | Education | In-kind items and services | C3 Wave Device, Vascular Access | 2020 | |
| 2020-12-31 | AngioDynamics, Inc. | $34 | Education | In-kind items and services | C3 Wave Device, Vascular Access | 2020 | |
| 2020-12-31 | AngioDynamics, Inc. | $34 | Education | In-kind items and services | C3 Wave Device, Vascular Access | 2020 | |
| 2020-12-31 | Masimo Corporation | $31 | Education | In-kind items and services | SedLine Device, Devices | 2020 | |
| 2020-11-16 | Boston Scientific Corporation | $1,771 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-11-16 | Boston Scientific Corporation | $1,239 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-11-16 | Boston Scientific Corporation | $800 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-11-10 | Linvatec Corporation | $6,863 | Grant | In-kind items and services | FLUID MANAGEMENT/PUMPS Device, ORTHOPEDIC SURGERY | 2020 | |
| 2020-11-05 | Novartis Pharmaceuticals Corporation | $15,580 | Research payment | Cash or cash equivalent | MBG453 Biological | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III MULTI-CENTER STUDY OF AZACITIDINE WITH OR WITHOUT MBG453 FOR TH | 2020 |
| 2020-10-22 | Surmodics, Inc. | $300 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-10-22 | Surmodics, Inc. | $300 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-10-22 | Surmodics, Inc. | $100 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-10-22 | Surmodics, Inc. | $100 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-10-22 | Surmodics, Inc. | $100 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-10-21 | Masimo Corporation | $25 | Education | In-kind items and services | SedLine Device, Devices | 2020 | |
| 2020-09-16 | Merck Sharp & Dohme LLC | $32,400 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | A MULTICENTER PHASE 2, OPEN-LABEL TRIAL OF INTRATUMORAL PIL-12 PLUS ELECTROPORATION IN COMBINATION WITH INTRAVENOUS PEMB | 2020 |
| 2020-09-10 | Surmodics, Inc. | $1,341 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-09-08 | Boston Scientific Corporation | $1,365 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-08-17 | Boston Scientific Corporation | $500 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | SFA DES PIVOTAL | 2020 |
| 2020-08-13 | Surmodics, Inc. | $1,239 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-07-31 | Surmodics, Inc. | $1,543 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-07-31 | Surmodics, Inc. | $1,543 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-07-06 | Boston Scientific Corporation | $600 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-07-06 | Boston Scientific Corporation | $572 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-07-06 | Boston Scientific Corporation | $572 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-07-06 | Boston Scientific Corporation | $150 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-06-22 | Boston Scientific Corporation | $802 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | SFA DES PIVOTAL | 2020 |
| 2020-06-11 | Surmodics, Inc. | $500 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-05-18 | Boston Scientific Corporation | $1,500 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | SFA DES PIVOTAL | 2020 |
| 2020-05-18 | Boston Scientific Corporation | $500 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | SFA DES PIVOTAL | 2020 |
| 2020-05-15 | Surmodics, Inc. | $1,000 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-04-24 | Surmodics, Inc. | $1,169 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-04-24 | Surmodics, Inc. | $540 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-04-06 | Boston Scientific Corporation | $3,806 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-03-09 | STERIS CORPORATION | $250 | Gift | Cash or cash equivalent | 2020 | ||
| 2020-03-02 | Eli Lilly and Company | $5,500 | Research payment | Cash or cash equivalent | A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD | 2020 | |
| 2020-02-26 | Incyte Corporation | $1,250 | Research payment | Cash or cash equivalent | Evaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S | 2020 | |
| 2020-02-20 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-02-18 | Boston Scientific Corporation | $401 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | SFA DES PIVOTAL | 2020 |
| 2020-02-18 | Boston Scientific Corporation | $200 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-02-18 | Boston Scientific Corporation | $56 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | INSIGHT ATP | 2020 |
| 2020-02-13 | Surmodics, Inc. | $500 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-01-23 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2020 | ||
| 2020-01-22 | Incyte Corporation | $5,628 | Research payment | Cash or cash equivalent | Evaluation Of Ruxolitinib And Azacytidine Combination As A Therapy For Patients With Myelofibrosis And Myelodysplastic S | 2020 | |
| 2020-01-21 | Boston Scientific Corporation | $401 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | SFA DES PIVOTAL | 2020 |
| 2020-01-21 | Boston Scientific Corporation | $400 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | SFA DES PIVOTAL | 2020 |
| 2020-01-14 | Surmodics, Inc. | $7,500 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-01-14 | Surmodics, Inc. | $848 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-01-14 | Surmodics, Inc. | $572 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-01-07 | Eli Lilly and Company | $18,327 | Research payment | Cash or cash equivalent | A MULTICENTER, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY OF ABEMACICLIB, A CDK4 AND 6 INHIBITOR, IN COMBINATION WITH FULVE | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Yuma, AZ, county Yuma County, AZ, state Arizona; placed by its city name.
| Measure | Place (city or town) Yuma, AZ | County Yuma County, AZ | State Arizona |
|---|---|---|---|
| Population B01003 | 100,139 | 211,741 | 7,378,838 |
| Population, 2020 census P1 | 95,548 | 203,881 | 7,151,502 |
| Median age B01002 | 33.1 | 36.1 | 39.0 |
| Under 18 B01001 | 25.5% | 24.6% | 21.6% |
| 65 and over B01001 | 17.6% | 20.7% | 18.9% |
| Households B11001 | 39,110 | 79,341 | 2,856,081 |
| Foreign born B05002 | 19.5% | 25.1% | 13.0% |
| Median household income B19013 | $65,482 | $62,876 | $79,964 |
| Median family income B19113 | $73,504 | $71,136 | $95,980 |
| Per capita income B19301 | $33,951 | $30,204 | $42,503 |
| Poverty rate B17001 | 15.5% | 15.6% | 12.5% |
| Unemployment rate B23025 | 6.3% | 6.9% | 5.1% |
| Civilian labor force B23025 | 42,858 | 83,296 | 3,598,840 |
| Mean commute (minutes) B08013 | 18.4 | 21.3 | 25.4 |
| Bachelor's degree or higher B15003 | 20.9% | 16.8% | 33.3% |
| Housing units B25001 | 44,663 | 95,200 | 3,192,839 |
| Owner-occupied B25003 | 66.8% | 71.0% | 67.4% |
| Renters B25003 | 33.2% | 29.0% | 32.6% |
| Median home value B25077 | $230,000 | $217,800 | $394,500 |
| Median gross rent B25064 | $1,114 | $993 | $1,543 |
| White, not Hispanic B03002 | 31.2% | 29.0% | 52.6% |
| Black B03002 | 1.9% | 1.5% | 4.4% |
| Hispanic or Latino B03002 | 60.8% | 64.9% | 31.4% |
| Asian B03002 | 1.7% | 1.0% | 3.5% |
| American Indian and Alaska Native B03002 | 0.7% | 0.8% | 3.2% |
Economy now FRED unemployment 4.9% in Sep 2026 (4.4% a year earlier); per capita personal income $68,373 in 2025, up 31% in five years (+5.7% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Yuma, AZ.
Comments